Akebia Therapeutics AKBA Income Statement (2013-2026)

NASDAQ AKBA
$0.89 +0.01 (+0.59%)
At close: Aug 20, 2026 · 12:47 PM UTC
Income Statement Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
48.76M-152.07M0.08M126.36M48.71M55.78M40.01M56.38M42.05M56.20M32.61M43.65M37.43M46.50M57.34M62.47M58.77M57.62M53.54M49.13M
Cost of Revenue (Quarter)
6.93M11.59M23.11M18.60M38.28M23.60M11.18M17.28M18.01M9.65M11.61M17.05M5.15M11.36M7.62M9.92M9.38M12.54M12.29M10.42M
Gross Profit (Quarter)
41.82M-163.66M-23.03M107.77M10.43M32.18M28.83M39.09M24.04M46.54M21.00M26.60M32.28M35.14M49.71M52.55M49.38M45.09M41.25M38.70M
Operating items
Amortization - Intangibles (Quarter)
9.01M9.01M9.01M9.01M9.01M9.01M9.01M9.01M9.01M9.01M9.01M9.01M9.01M9.01M
Research & Development (Quarter)
40.47M29.56M43.83M26.03M28.03M32.10M19.69M20.20M13.33M9.87M9.73M7.65M8.49M11.79M9.75M11.01M14.94M1.00M14.81M14.06M
Selling, General & Administrative (Quarter)
46.36M44.80M44.57M32.24M31.89M29.91M25.05M27.04M22.71M25.44M25.44M26.92M26.52M27.68M25.74M26.55M29.09M26.09M30.44M28.17M
Restructuring Costs (Quarter)
14.53M0.18M1.22M0.11M-0.09M0.17M0.06M1.95M
Other Operating Expenses (Quarter)
0.87M1.03M0.45M0.89M0.74M0.85M0.57M0.95M0.86M0.86M0.71M0.76M0.77M0.98M0.70M0.90M0.90M26.55M0.71M0.85M
Operating Expenses (Quarter)
87.70M75.39M88.85M73.69M60.84M64.08M45.41M48.09M37.07M36.16M35.94M35.33M35.77M40.44M36.20M38.46M44.93M53.64M45.95M45.03M
Operating Income (Quarter)
-54.89M-65.34M-59.58M34.08M-50.41M-4.87M-25.60M-9.00M-13.04M1.37M-14.94M-8.72M-12.51M-14.31M13.51M14.09M4.45M-8.55M-4.70M-6.33M
EBIT (Quarter)
-54.89M-65.34M-59.58M34.08M-50.41M-4.87M-25.60M-9.00M-13.04M1.37M-14.94M-8.72M-12.51M-14.31M13.51M14.09M4.45M-8.55M-4.70M-6.33M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)
0.43M0.56M1.13M0.41M1.17M-0.01M-0.27M0.89M-0.52M-0.04M0.61M0.21M-0.03M-0.01M0.06M0.00M-0.01M
Non Operating Income (Quarter)
-5.08M-5.08M-5.06M-5.04M-3.95M-1.64M-1.56M-1.64M-1.41M-1.42M-2.50M-2.15M-6.66M-6.88M-7.77M-6.83M-4.75M-4.83M-4.69M-3.07M
Net income details
EBT (Quarter)
-57.59M-68.14M-62.28M31.38M-52.51M-4.12M-26.88M-11.17M-14.49M0.61M-17.98M-8.58M-20.04M-22.80M6.11M0.25M1.16M-11.23M-8.93M-8.84M
Tax Provisions (Quarter)
0.61M1.01M0.13M0.07M
Profit After Tax (Quarter)
-59.54M-69.86M-63.51M29.45M-54.10M-6.07M-26.88M-11.17M-14.49M0.61M-17.98M-8.58M-20.04M-22.80M6.11M0.25M0.54M-12.24M-9.05M-8.91M
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)
-57.59M-68.14M-62.28M31.38M-52.51M-4.12M-26.88M-11.17M-14.49M0.61M-17.98M-8.58M-20.04M-22.80M6.11M0.25M0.54M-12.24M-9.05M-8.91M
Consolidated Net Income (Quarter)
-57.59M-68.14M-62.28M31.38M-52.51M-4.12M-26.88M-11.17M-14.49M0.61M-17.98M-8.58M-20.04M-22.80M6.11M0.25M0.54M-12.24M-9.05M-8.91M
Income towards Parent Company (Quarter)
-57.59M-68.14M-62.28M31.38M-52.51M-4.12M-26.88M-11.17M-14.49M0.61M-17.98M-8.58M-20.04M-22.80M6.11M0.25M0.54M-12.24M-9.05M-8.91M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-59.54M-68.14M-63.51M29.45M-54.10M-4.12M-26.88M-11.17M-14.49M0.61M-17.98M-8.58M-20.04M-22.80M6.11M0.25M0.54M-12.24M-9.05M-8.91M
Additional items
EPS (Basic) (Quarter)
-0.34-0.41-0.350.16-0.29-0.02-0.15-0.06-0.080.00-0.09-0.04-0.10-0.110.030.000.00-0.05-0.03-0.03
EPS (Diluted) (Quarter)
-0.34-0.41-0.350.15-0.29-0.02-0.15-0.06-0.080.00-0.09-0.04-0.10-0.110.030.000.00-0.05-0.03-0.03
Shares Outstanding (Quarter)
173.78M165.95M179.60M183.60M183.88M182.78M184.77M186.82M188.31M187.47M204.96M209.71M210.35M210.95M235.50M262.57M264.79M257.16M267.05M269.60M
Shares Outstanding (Diluted) (Quarter)
173.78M165.95M179.60M190.38M183.88M182.78M184.77M186.82M188.31M187.47M204.96M209.71M210.35M210.95M241.60M271.10M274.37M257.16M267.05M269.60M
Shares Outstanding (Entity) (Quarter)
174.55M177.00M183.39M183.70M183.95M184.14M185.84M188.13M188.31M194.58M209.45M209.93M211.54M224.85M261.64M263.04M265.23M265.42M267.90M271.74M
EBITDA (Quarter)
-54.89M-65.34M-59.58M34.08M-50.41M-4.87M-25.60M-9.00M-13.04M1.37M-14.94M-8.72M-12.51M-14.31M13.51M14.09M4.45M-8.55M-4.70M-6.33M
Interest Expenses (Quarter)
2.70M2.80M2.70M2.70M2.10M-0.74M1.80M1.60M1.40M1.36M1.40M1.60M1.70M-0.47M2.10M28.38M15.16M4.00M3.55M7.65M
Tax Rate (Quarter)
53.25%-8.98%-1.41%-0.79%